![](https://oversight.house.gov/wp-content/uploads/2024/07/Comer-5-1024x576.png)
Hearing Wrap Up: Oversight Committee Exposes How PBMs Undermine Patient Health and Increase Drug Costs
WASHINGTON—Today, the House Committee on Oversight and Accountability held a hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.” At the hearing, Republicans and Democrats pressed …